Headquartered in Louisville, Kentucky, with nearly $2 billion in annual revenues, PharMerica is one of the largest and fastest growing institutional pharmacy companies in America. We are a premier pharmacy services provider dedicated to providing innovative solutions for customers and patients. At PharMerica, you can choose your career path – hospital pharmacy, long term care pharmacy, corporate and non-clinical opportunities. We employ some of the industry’s best and brightest innovators and clinicians. With more than 100 long-term care pharmacies in over 45 states nationwide, PharMerica employs approximately 5,500 dedicated employees and pharmacy professionals. We offer our staff the opportunity to learn the business and cross train in other areas to provide a catalyst for their career growth within PharMerica. We also recruit our next generation of leaders by hiring new graduates from some of the nation’s top pharmacy and business schools. In addition, we offer educational opportunities through internships and our management training program. As a fast growing organization, we can provide you with the opportunity to kick start your career or advance your skills using some of the industry’s state-of-the-art technology. We foster an environment that encourages our high performers. Because we are a national company, we can provide opportunities for employees that desire to relocate. In addition, we offer a comprehensive benefits package that supports your quality of life.
Louisville, US
Size (employees)
5,700 (est)-1%
Pharmerica was founded in 2007 and is headquartered in Louisville, US

Pharmerica Office Locations

Pharmerica has an office in Louisville
Louisville, US (HQ)
1901 Campus Pl

Pharmerica Metrics

Pharmerica Financial Metrics

Revenue (2016)

$2.1 b

Revenue growth (2015-16), %


Gross profit

$326 m

Gross profit margin (2016), %


Net income (2016)

$21.6 m

Market capitalization (21-Mar-2017)

$712.8 m

Closing share price (21-Mar-2017)


Cash (31-Dec-2016)

$5.4 m
Pharmerica's current market capitalization is $712.8 m.
Pharmerica's revenue was reported to be $2.1 b in FY, 2016 which is a 3.1% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$1.8 b$1.9 b$2 b$2.1 b

Revenue growth, %


Cost of goods sold

$1.4 b$1.6 b$1.7 b$1.8 b

Gross profit

$327.2 m$339.3 m$335.1 m$326 m

Gross profit Margin, %



$55.8 m$30.4 m$53.8 m$38.4 m

EBIT margin, %


Interest income

$10.6 m$9.9 m$6.6 m$9.5 m

Pre tax profit

$45.2 m$16.2 m$47.2 m$28.9 m

Net Income

$18.9 m$6.8 m$35.1 m$21.6 m
FY, 2013FY, 2014FY, 2015FY, 2016


$24.2 m$33.3 m$23.1 m$5.4 m

Accounts Receivable

$199.8 m$195.7 m$200.5 m$235.4 m


$110.3 m$135.7 m$155.2 m$214.7 m

Current Assets

$411.7 m$497.3 m$483.5 m$552.4 m


$282.6 m$317.7 m$371 m$392.3 m

Total Assets

$901.4 m$1.1 b$1.2 b$1.3 b

Accounts Payable

$83.8 m$95.5 m$71.7 m$107.1 m

Total Debt

$231.3 m$351.3 m$427.3 m$473.4 m

Current Liabilities

$151.5 m$175.8 m$141.4 m$182.3 m

Additional Paid-in Capital

$380.2 m$394.1 m$404.6 m$411.1 m

Retained Earnings

$110.2 m$117 m$152.1 m$173.7 m

Total Equity

$462.5 m$478.1 m$519.4 m$544.2 m

Debt to Equity Ratio

0.5 x0.7 x0.8 x0.9 x

Debt to Assets Ratio

0.3 x0.3 x0.4 x0.4 x

Financial Leverage

1.9 x2.2 x2.2 x2.4 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$4.4 m$6.8 m$35.1 m$21.6 m

Depreciation and Amortization

$15.4 m$20.3 m$23.1 m$23.8 m

Accounts Receivable

$29.1 m($2.4 m)($34 m)


($19 m)($16 m)($57 m)

Accounts Payable

($2.9 m)($24 m)$36.4 m

Cash From Operating Activities

$48.4 m$18.5 m$30.8 m

Cash From Investing Activities

($157 m)($104.1 m)($91.7 m)

Long-term Borrowings

($231.3 m)($5.6 m)($11.3 m)

Cash From Financing Activities

$117.7 m$75.4 m$43.2 m

Interest Paid

$7.8 m$8.5 m$10.6 m

Income Taxes Paid

$5.3 m$19.4 m($4.8 m)

Pharmerica Market Value History

Pharmerica Online Presence

Pharmerica Company Life

You may also be interested in